In our previous studies [22,23], we identified the class II major histocompatibility complex transactivator (CIITA) gene as an important interactor of HDAC2 and consequently, of major histocompatibility complex (MHC) class II regulatory genes, which contribute to CRC progression. The gene discussed is HDAC2; the disease is colorectal carcinoma.